AbbVie lifts profit forecast on strong sales of newer immunology drugs
(Reuters) -AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq ...
Read moreDetailsTag: abbvie
Hope for Parkinson’s disease symptoms is found in late-stage drug study todayheadline
Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. Read More
Read moreDetails
